Dorothy Clarke, Board Member at Comera Life Sciences (NASDAQ:CMRA), reported a large acquisition of company stock options on November 13, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Clarke, Board Member at Comera Life Sciences, a company in the Health Care sector, was just awarded stock options worth 14,200 shares of CMRA. The options give Clarke the right to buy the company's stock at $0.35 per share.
Comera Life Sciences shares are trading up 13.35% at $0.28 at the time of this writing on Monday morning. Since the current price is $0.28, this makes Clarke's 14,200 shares worth $4,025.